RAHWAY, N.J.–(BUSINESS WIRE)—- $MRK #MRK–Sac-TMT Reduced the Risk of Death by 32% and the Risk of Disease Progression or Death by 41% Compared to Chemotherapy in TroFuse-005 Trial

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.